AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

Search

Haleon PLC

Closed

SectorHealthcare

403.1 0.6

Overview

Share price change

24h

Current

Min

400.6

Max

406.4

Key metrics

By Trading Economics

Income

-254M

231M

Sales

-21M

2.8B

P/E

Sector Avg

24.919

56.602

EPS

0.042

Dividend yield

1.66

Profit margin

8.373

Employees

24,561

EBITDA

-317M

399M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+5.65% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.66%

2.45%

Next Earnings

31 Jul 2025

Next Ex Dividend date

14 Aug 2025

Market Stats

By TradingEconomics

Market Cap

1.9B

36B

Previous open

402.5

Previous close

403.1

News Sentiment

By Acuity

31%

69%

88 / 382 Healthcare

Haleon PLC Chart

Past performance is not a reliable indicator of future results.

Related News

15 Apr 2025, 09:37 UTC

Acquisitions, Mergers, Takeovers

Haleon Acquires Chinese JV in $264 Million Deal

19 Mar 2025, 07:34 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 Mar 2025, 17:26 UTC

Acquisitions, Mergers, Takeovers

Pfizer to Dispose of Remaining Shareholding in Haleon

30 Apr 2025, 08:33 UTC

Market Talk
Earnings

Haleon's Vitamins & Supplements Business Weakness in Focus Among Results -- Market Talk

30 Apr 2025, 06:09 UTC

Earnings

Haleon Expects Macroeconomic Environment to Remain Challenging, Uncertain

30 Apr 2025, 06:09 UTC

Earnings

Haleon Continues to Deliver Against Capital Allocation Priorities

30 Apr 2025, 06:08 UTC

Earnings

Analysts Saw Haleon 1Q Organic Revenue Growth at 5.1%

30 Apr 2025, 06:03 UTC

Earnings

Haleon Sees 2025 Adjusted Operating Profit Growth Ahead of Revenue Growth

30 Apr 2025, 06:03 UTC

Earnings

Haleon Sees 2025 Organic Revenue Growth of 4%-6%

30 Apr 2025, 06:03 UTC

Earnings

Haleon Backs 2025 View

30 Apr 2025, 06:03 UTC

Earnings

Haleon 1Q Rev GBP2.85B

30 Apr 2025, 06:01 UTC

Earnings

Haleon 1Q Organic Revenue Growth up 3.5%

29 Apr 2025, 19:47 UTC

Earnings

Pfizer Shares Rise on CEO's Optimism on Threatened Drug Tariffs -- Barrons.com

15 Apr 2025, 09:03 UTC

Acquisitions, Mergers, Takeovers

Haleon: Deal Expected to Close Within Next Three Mos

15 Apr 2025, 09:03 UTC

Acquisitions, Mergers, Takeovers

Haleon Has Bought Last 12% Interest for GBP200M

15 Apr 2025, 09:02 UTC

Acquisitions, Mergers, Takeovers

Haleon Bought 33% interest in December 2024

15 Apr 2025, 09:02 UTC

Acquisitions, Mergers, Takeovers

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical from Tianjin Pharmaceutical Da Ren Tang

15 Apr 2025, 09:01 UTC

Acquisitions, Mergers, Takeovers

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical

18 Mar 2025, 16:58 UTC

Acquisitions, Mergers, Takeovers

Haleon Intends to Cancel Purchased Ordinary Shares

18 Mar 2025, 16:57 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 Mar 2025, 16:56 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 Mar 2025, 16:56 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 Mar 2025, 16:52 UTC

Acquisitions, Mergers, Takeovers

Haleon Takes Note of Announcement

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: This Is Subject to Customary Closing Conditions

18 Mar 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Bookbuilding Period Will Commence Immediately

18 Mar 2025, 16:49 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 Mar 2025, 16:48 UTC

Acquisitions, Mergers, Takeovers

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

Peer Comparison

Price change

Haleon PLC Forecast

Price Target

By TipRanks

5.65% upside

12 Months Forecast

Average 416.67 GBX  5.65%

High 475 GBX

Low 315 GBX

Based on 12 Wall Street analysts offering 12 month price targets forHaleon PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

7

Buy

4

Hold

1

Sell

Sentiment

By Acuity

88 / 382 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.